Announcements Trials
Browse Landscape

Phase

Phase 3 8Phase NA 3Phase 4 3Phase 2 2

Status

Completed 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Genitourinary 1

Conditions

Osteoporosis 2Breast Neoplasms 2Bone Diseases, Metabolic 2Prostatic Neoplasms 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Risedronic Acid × Clear all
NCT00859027 2018-05-01

Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer

UConn Health

Phase 4 Completed
50 enrolled 7 charts
Genitourinary

Prostatic Neoplasms

NCT00485953 2017-10-13

REBBeCA II

University of Pittsburgh

Phase 4 Completed
109 enrolled 11 charts
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT00082277 2011-01-26

SABRE

AstraZeneca

Phase 4 Completed
237 enrolled
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡